jama semaglutide vs tirzepatide Most viewed this week from JAMA: Between 2021 and 2024, and prescriptions in Epic-affiliated health care systems increased slightly but remained limited, with only 3% of eligible patients receiving them JAMA Study Finds Mounjaro More

Doses below 0.2mg may bind a small receptor population but fail to generate the tyrosinase upregulation density required for visible tanning

Month 1-2: Keep It Light During the initial side effect period, light exercise is appropriate

Novo Nordisk's expected regulatory filings later in 2026 will be closely watched by clinicians, patients, and families alike

Pharmaceutical manufacturers must reevaluate the list price and implement more affordability programs to help consumers prescribed GIP and GLP-1 medications for obesity

Clinicians should note that FDA labeling emphasizes the importance of patient education about gastrointestinal side effects and maintaining adequate hydration